| Literature DB >> 33606578 |
Ziling Zhang1, Lanlan Dong1, Chen Zhao1, Peiyong Zheng2, Xiaoyan Zhang1,3, Jianqing Xu1,3.
Abstract
Vaccinia virus was used to prevent smallpox. After the World Health Organization declared smallpox extinct, vaccinia virus has been explored for the development of vaccines against a variety of infectious diseases. It also finds a new place in oncolytic therapy. Here we provide a brief review of the history, current status, and future prospect of vaccinia virus-based vaccine and oncolytic virus. New advancements, including a single vaccine targeting multiple viruses, strategies of arming vaccinia viruses to enhance anti-tumor activity, the promise and challenge of combining vaccinia-based virotherapy with immunotherapy, are discussed as special focus.Entities:
Keywords: Tiantan strain; Vaccinia virus; oncolytic virus; tumor; vaccine vector
Mesh:
Year: 2021 PMID: 33606578 PMCID: PMC8115763 DOI: 10.1080/21645515.2020.1840887
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452